A Phase I/II Study of Personalized Immunotherapy in Adults With Upper Gastrointestinal Tract Cancers
Status:
Not yet recruiting
Trial end date:
2026-06-01
Target enrollment:
Participant gender:
Summary
The purpose of this study is to determine if it is possible to make and safely administer a
'personalized' cancer vaccine for people diagnosed with an upper gastrointestinal tract
cancer.